The Impact of AI and Digital Biomarkers on the Alzheimer’s Disease Diagnostic Market
Artificial intelligence is becoming the "Invisible Specialist" in neurology clinics across the globe this year. In 2026, the Alzheimer’s Disease Diagnostic Market is witnessing a 25 percent improvement in early detection rates thanks to the integration of AI-driven diagnostic platforms. These systems, such as the newly developed DementAI, analyze existing clinical records and structured...
0 Reacties
0 aandelen
275 Views